WCM Investment Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-107,032
Closed -$8.09M 249
2025
Q3
$8.09M Sell
107,032
-3,701
-3% -$375K 0.02% 152
2025
Q2
$14.7M Buy
110,733
+37,873
+52% +$5.49M 0.03% 125
2025
Q1
$11.5M Buy
72,860
+17,125
+31% +$3.1M 0.03% 134
2024
Q4
$10.3M Buy
+55,735
New +$10.8M 0.02% 154
2023
Q3
Sell
-38,540
Closed -$12.3M 215
2023
Q2
$12.3M Buy
+38,540
New +$11M 0.04% 125
2020
Q2
Sell
-89,935
Closed -$5.42M 189
2020
Q1
$5.42M Buy
89,935
+25,050
+39% +$1.85M 0.03% 100
2019
Q4
$4.82M Buy
64,885
+54,665
+535% +$3.51M 0.03% 114
2019
Q3
$624K Buy
+10,220
New +$673K ﹤0.01% 136

Other funds holding INSP

WCM Investment Management's INSP Position: Q4 2025 in Review

WCM Investment Management sold out of Inspire Medical Systems (INSP) in Q4 2025, closing a stake of 107,032 shares — an estimated $8.09M sold.

WCM Investment Management first reported a position in INSP in Q3 2019 and held it in 8 quarters. The position peaked at $14.7M in Q2 2025. 342 funds tracked by Wall St. Rank hold INSP as of Q4 2025.

  • WCM Investment Management reported no remaining Inspire Medical Systems position as of Q4 2025 after selling out during the quarter.
  • WCM Investment Management sold 107,032 Inspire Medical Systems shares in Q4 2025, an estimated $8.09M.
  • WCM Investment Management first reported a position in Inspire Medical Systems in Q3 2019 and held it in 8 quarters.
  • WCM Investment Management's Inspire Medical Systems position peaked at $14.7M in Q2 2025.
  • 342 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2025.

Based on WCM Investment Management's 13F filing for Q4 2025, filed 9 Feb 2026.